Chongqing Intracerebral Hemorrhage Study

Chongqing Medical University

Status: Unknown

Conditions: Stroke; Intracerebral Hemorrhage; Hematoma

Study type: Observational

Funder types: Other

Identifiers

NCT03085472

X1517

Details and patient eligibility

About

The Chongqing intracerebral hemorrhage study is a multi-center, prospective, observational study led by professor Qi Li from Chongqing Medical University. Professor Peng Xie will be the senior consultant for the study. The Chongqing intracerebral hemorrhage study will focus on the epidemiology, natural history, pathogenesis, laboratory, radiological aspects, clinical outcomes and the effects of treatment in patients with intracerebral hemorrhage.

The clinical, laboratory, imaging, genetic and outcome data of patients diagnosed with acute intracerebral hemorrhage will be prospectively collected. The prognosis of patients with intracerebral hemorrhage will be assessed by using several outcome measure scales at different time points.

Full description

The Chongqing intracerebral hemorrhage study will try to address several key issues in ICH. The baseline clinical data including demographic, disease severity scores, prior drug history and relevant medical history, premorbid mRS scores will be prospectively recorded. The admission and follow-up imaging data of all registered patients will be saved as Dicom format for future use and review. The functional outcomes will be assessed and recorded by experienced neurologists.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >= 18 years
• Informed consent to participate in the study
• Patients diagnosed with CT-confirmed spontaneous Intracerebral Hemorrhage (ICH)
• Patients are willing to participate in the follow up assessment

Exclusion criteria

• Did not agree to participate in the study
• Secondary ICH to hemorrhagic infarction or tumor bleeding etc.
• Traumatic ICH

Trial design

1,000 participants in 2 patient groups

benigh hematoma

Description:

Patients with novel imaging markers or clinical features suggestive of a relatively benigh hematoma (less likely to expand and have a relatively good outcome).

malignant hematoma

Description:

Patients with novel imaging markers or clinical features suggestive of a relatively bad hematoma (more likely to expand and have a relatively poor outcome).